I would think that samples of products used during the trial are required to be kept for future testing and analysis should the need arise. Great buying opportunity at this price.
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1503 Acne Phase 2 Study Results Presentation
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-103
-
-
- There are more pages in this discussion • 548 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.3¢ |
Change
0.003(0.66%) |
Mkt cap ! $696.8M |
Open | High | Low | Value | Volume |
38.0¢ | 39.0¢ | 38.0¢ | $735.5K | 1.920M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 207656 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 354596 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 182656 | 0.380 |
6 | 113098 | 0.375 |
12 | 422300 | 0.370 |
8 | 584879 | 0.365 |
9 | 304192 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 369958 | 14 |
0.390 | 803412 | 12 |
0.395 | 567954 | 14 |
0.400 | 802439 | 21 |
0.405 | 247450 | 8 |
Last trade - 11.04am 16/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online